| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2015 | 305 | 0.570 |
Why?
|
| Lymphoma, T-Cell | 2 | 2015 | 361 | 0.510 |
Why?
|
| Pathology, Molecular | 1 | 2015 | 128 | 0.500 |
Why?
|
| Immunophenotyping | 4 | 2016 | 1681 | 0.440 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 2012 | 31 | 0.440 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2012 | 179 | 0.400 |
Why?
|
| Translocation, Genetic | 2 | 2015 | 1245 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2012 | 402 | 0.380 |
Why?
|
| PTEN Phosphohydrolase | 7 | 2009 | 986 | 0.370 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2009 | 476 | 0.360 |
Why?
|
| Retroviridae Proteins, Oncogenic | 2 | 1998 | 36 | 0.330 |
Why?
|
| ras Proteins | 1 | 2012 | 770 | 0.320 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 2488 | 0.230 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 2012 | 57 | 0.220 |
Why?
|
| Leukemia, Myeloid, Acute | 5 | 2023 | 6915 | 0.210 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2002 | 243 | 0.190 |
Why?
|
| Apoptosis | 5 | 2016 | 7591 | 0.190 |
Why?
|
| Chromosome Aberrations | 2 | 2011 | 1960 | 0.180 |
Why?
|
| Mutation | 5 | 2018 | 15179 | 0.170 |
Why?
|
| Oncogene Proteins v-rel | 4 | 2006 | 7 | 0.170 |
Why?
|
| Cysteine Endopeptidases | 2 | 2016 | 251 | 0.170 |
Why?
|
| Neoplastic Stem Cells | 3 | 2015 | 1443 | 0.170 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2018 | 3552 | 0.160 |
Why?
|
| Cloning, Molecular | 2 | 2006 | 1213 | 0.160 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2013 | 2359 | 0.150 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2018 | 221 | 0.140 |
Why?
|
| Proteins | 3 | 2009 | 1963 | 0.140 |
Why?
|
| Cell Proliferation | 8 | 2016 | 7226 | 0.130 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 1360 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2005 | 1823 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2014 | 166 | 0.120 |
Why?
|
| Tumor Suppressor Protein p14ARF | 2 | 2006 | 97 | 0.120 |
Why?
|
| Animals | 21 | 2018 | 59536 | 0.120 |
Why?
|
| Glycolysis | 1 | 2016 | 519 | 0.120 |
Why?
|
| Cytogenetic Analysis | 1 | 2015 | 568 | 0.120 |
Why?
|
| Receptors, Immunologic | 1 | 2015 | 309 | 0.110 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2008 | 1064 | 0.110 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 2012 | 11 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2016 | 8873 | 0.110 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2012 | 47 | 0.110 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2012 | 173 | 0.100 |
Why?
|
| Hydroxyurea | 1 | 2012 | 204 | 0.100 |
Why?
|
| Mice, Knockout | 7 | 2015 | 5710 | 0.100 |
Why?
|
| Embryo Loss | 1 | 2010 | 42 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 507 | 0.100 |
Why?
|
| Genes, Lethal | 1 | 2010 | 120 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2012 | 829 | 0.090 |
Why?
|
| RecQ Helicases | 1 | 2010 | 102 | 0.090 |
Why?
|
| Leukemia, Experimental | 1 | 2009 | 78 | 0.090 |
Why?
|
| Glioblastoma | 3 | 2009 | 1797 | 0.090 |
Why?
|
| Haploidy | 1 | 2008 | 40 | 0.080 |
Why?
|
| Dyskeratosis Congenita | 1 | 2008 | 26 | 0.080 |
Why?
|
| Gene Rearrangement | 1 | 2012 | 783 | 0.080 |
Why?
|
| Receptor, Notch1 | 1 | 2009 | 218 | 0.080 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2010 | 388 | 0.080 |
Why?
|
| Gene Deletion | 2 | 2014 | 1442 | 0.080 |
Why?
|
| Cell Line, Tumor | 8 | 2016 | 14551 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2011 | 2232 | 0.080 |
Why?
|
| MicroRNAs | 2 | 2023 | 2947 | 0.080 |
Why?
|
| Myocardium | 1 | 2014 | 1313 | 0.080 |
Why?
|
| Transfection | 3 | 2016 | 2944 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2011 | 3033 | 0.080 |
Why?
|
| Chick Embryo | 3 | 2006 | 242 | 0.080 |
Why?
|
| Mice | 13 | 2016 | 34495 | 0.070 |
Why?
|
| Genes, myc | 1 | 2009 | 358 | 0.070 |
Why?
|
| Brain Neoplasms | 3 | 2009 | 4849 | 0.070 |
Why?
|
| Genes, rel | 1 | 2006 | 8 | 0.070 |
Why?
|
| Humans | 26 | 2023 | 261506 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2012 | 997 | 0.070 |
Why?
|
| Cell Differentiation | 3 | 2009 | 4078 | 0.070 |
Why?
|
| Temperature | 2 | 1998 | 506 | 0.070 |
Why?
|
| Histiocytic Disorders, Malignant | 1 | 2006 | 6 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 6942 | 0.070 |
Why?
|
| Base Sequence | 4 | 2016 | 4917 | 0.070 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 1331 | 0.070 |
Why?
|
| DNA-Binding Proteins | 4 | 2010 | 4821 | 0.070 |
Why?
|
| Aging | 1 | 2014 | 1582 | 0.070 |
Why?
|
| Telomerase | 1 | 2008 | 525 | 0.070 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2006 | 177 | 0.070 |
Why?
|
| Kidney | 1 | 2014 | 2146 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2012 | 4233 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2005 | 542 | 0.060 |
Why?
|
| Neurons | 2 | 2008 | 2287 | 0.060 |
Why?
|
| Myeloid Cells | 1 | 2006 | 269 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 2010 | 2022 | 0.060 |
Why?
|
| Genes, p53 | 1 | 2009 | 1090 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2016 | 2326 | 0.060 |
Why?
|
| Liver | 1 | 2014 | 2961 | 0.060 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2014 | 1664 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2012 | 6089 | 0.060 |
Why?
|
| Alleles | 3 | 2018 | 2437 | 0.060 |
Why?
|
| Osteosarcoma | 1 | 2010 | 929 | 0.060 |
Why?
|
| Transformation, Genetic | 2 | 2002 | 57 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2016 | 3022 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 5178 | 0.050 |
Why?
|
| Cell Cycle Proteins | 2 | 2008 | 2045 | 0.050 |
Why?
|
| Lymphoma | 1 | 2010 | 1467 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 1998 | 3203 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2009 | 1283 | 0.050 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 241 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2009 | 6150 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 3 | 2012 | 1165 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2010 | 3343 | 0.050 |
Why?
|
| DNA, Complementary | 2 | 2006 | 869 | 0.050 |
Why?
|
| RNA Interference | 2 | 2016 | 1408 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 1 | 2008 | 1121 | 0.050 |
Why?
|
| Carcinogenesis | 2 | 2018 | 1026 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2006 | 1234 | 0.050 |
Why?
|
| Middle Aged | 7 | 2016 | 86204 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2014 | 5159 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2002 | 327 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2000 | 27 | 0.050 |
Why?
|
| DNA Damage | 1 | 2008 | 1954 | 0.050 |
Why?
|
| Phenotype | 3 | 2014 | 6295 | 0.050 |
Why?
|
| Bone Marrow | 2 | 2023 | 2358 | 0.050 |
Why?
|
| I-kappa B Proteins | 1 | 2000 | 170 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2011 | 2138 | 0.040 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1998 | 41 | 0.040 |
Why?
|
| Pheochromocytoma | 1 | 2002 | 281 | 0.040 |
Why?
|
| Male | 8 | 2016 | 123000 | 0.040 |
Why?
|
| Carcinoma | 1 | 2010 | 2578 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 2015 | 5395 | 0.040 |
Why?
|
| Heterozygote | 1 | 2002 | 1020 | 0.040 |
Why?
|
| Astrocytes | 1 | 2002 | 368 | 0.040 |
Why?
|
| Mice, SCID | 3 | 2009 | 1869 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2016 | 810 | 0.040 |
Why?
|
| Signal Transduction | 5 | 2016 | 11965 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2002 | 1471 | 0.040 |
Why?
|
| ErbB Receptors | 2 | 2008 | 2295 | 0.040 |
Why?
|
| Caspase 1 | 1 | 1997 | 64 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2005 | 5319 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 1997 | 394 | 0.040 |
Why?
|
| Chickens | 1 | 1997 | 523 | 0.040 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2002 | 489 | 0.040 |
Why?
|
| Glioma | 1 | 2008 | 1963 | 0.040 |
Why?
|
| Tumor Hypoxia | 1 | 2016 | 24 | 0.040 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 1997 | 202 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 318 | 0.040 |
Why?
|
| Genome, Human | 1 | 2005 | 1869 | 0.040 |
Why?
|
| Antibodies | 1 | 2000 | 838 | 0.040 |
Why?
|
| Cell Shape | 1 | 2016 | 128 | 0.040 |
Why?
|
| Remission Induction | 1 | 2023 | 3569 | 0.040 |
Why?
|
| Macrophages | 1 | 2023 | 1304 | 0.040 |
Why?
|
| Sumoylation | 1 | 2016 | 84 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1997 | 875 | 0.030 |
Why?
|
| Cell Line | 2 | 2006 | 5114 | 0.030 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2016 | 155 | 0.030 |
Why?
|
| Retroviridae | 2 | 2009 | 332 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 370 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2015 | 15 | 0.030 |
Why?
|
| Sarcoma | 1 | 2006 | 1725 | 0.030 |
Why?
|
| Prognosis | 3 | 2016 | 21713 | 0.030 |
Why?
|
| Neoplasms | 1 | 2002 | 15193 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2016 | 343 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2015 | 54 | 0.030 |
Why?
|
| DNA Primers | 1 | 1997 | 1399 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2016 | 626 | 0.030 |
Why?
|
| Stem Cells | 1 | 2002 | 1213 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 376 | 0.030 |
Why?
|
| Proteolysis | 1 | 2016 | 370 | 0.030 |
Why?
|
| Female | 8 | 2018 | 141928 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 392 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 194 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 5112 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 15694 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2014 | 246 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 560 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 703 | 0.030 |
Why?
|
| Injections | 1 | 2014 | 285 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2014 | 315 | 0.030 |
Why?
|
| Culture Media, Serum-Free | 1 | 2012 | 74 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2000 | 1549 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1997 | 854 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 2005 | 11538 | 0.030 |
Why?
|
| Culture Media | 1 | 2012 | 319 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 2864 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2014 | 1008 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2012 | 3536 | 0.030 |
Why?
|
| Young Adult | 3 | 2016 | 21445 | 0.030 |
Why?
|
| Transcription Factors | 3 | 2014 | 5270 | 0.030 |
Why?
|
| Time Factors | 2 | 2016 | 12926 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1077 | 0.030 |
Why?
|
| Melanoma | 1 | 2009 | 5317 | 0.030 |
Why?
|
| Neoplasm Proteins | 2 | 2005 | 3230 | 0.030 |
Why?
|
| Models, Animal | 1 | 2014 | 664 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2016 | 9180 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 2074 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2009 | 4143 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 591 | 0.020 |
Why?
|
| Adult | 4 | 2016 | 77950 | 0.020 |
Why?
|
| Retina | 1 | 2014 | 532 | 0.020 |
Why?
|
| Karyotyping | 1 | 2012 | 1022 | 0.020 |
Why?
|
| Blastocyst | 1 | 2010 | 124 | 0.020 |
Why?
|
| Aged | 4 | 2015 | 70117 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 4053 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2014 | 876 | 0.020 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2009 | 47 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 1618 | 0.020 |
Why?
|
| Gamma Rays | 1 | 2010 | 242 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2011 | 486 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 14289 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2008 | 2054 | 0.020 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2009 | 99 | 0.020 |
Why?
|
| Gene Expression | 1 | 1997 | 3570 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2016 | 13658 | 0.020 |
Why?
|
| Hematopoietic System | 1 | 2008 | 26 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 1489 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 12221 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2013 | 1742 | 0.020 |
Why?
|
| Cell Survival | 1 | 2015 | 3045 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 29902 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2009 | 475 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2010 | 306 | 0.020 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2008 | 19 | 0.020 |
Why?
|
| Monocytes | 1 | 2012 | 788 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 7222 | 0.020 |
Why?
|
| Hippocampus | 1 | 2014 | 915 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 3821 | 0.020 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2008 | 113 | 0.020 |
Why?
|
| Neutrophils | 1 | 2012 | 835 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2008 | 279 | 0.020 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2009 | 265 | 0.020 |
Why?
|
| Laminin | 1 | 2008 | 194 | 0.020 |
Why?
|
| Adolescent | 2 | 2012 | 31252 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2009 | 225 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 634 | 0.020 |
Why?
|
| Species Specificity | 1 | 2009 | 777 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2009 | 905 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 4307 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2008 | 259 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 699 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6207 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2008 | 5637 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 518 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 395 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2008 | 430 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 886 | 0.020 |
Why?
|
| Cell Death | 1 | 2008 | 671 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2008 | 621 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 191 | 0.020 |
Why?
|
| Plasmids | 1 | 2008 | 837 | 0.020 |
Why?
|
| src Homology Domains | 1 | 2006 | 124 | 0.020 |
Why?
|
| Telomere | 1 | 2008 | 505 | 0.020 |
Why?
|
| Cytogenetics | 1 | 2005 | 149 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 611 | 0.020 |
Why?
|
| Methylation | 1 | 2006 | 597 | 0.020 |
Why?
|
| Collagen | 1 | 2008 | 752 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2009 | 1581 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2008 | 943 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 460 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2005 | 311 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2008 | 778 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 3639 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2006 | 889 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2006 | 1764 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2012 | 6100 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2008 | 1620 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2002 | 51 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2005 | 534 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 1879 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2009 | 1546 | 0.010 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2005 | 461 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2005 | 745 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2005 | 829 | 0.010 |
Why?
|
| Oncogenes | 1 | 2005 | 673 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 289 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2008 | 1678 | 0.010 |
Why?
|
| Homeostasis | 1 | 2006 | 950 | 0.010 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2000 | 136 | 0.010 |
Why?
|
| Homozygote | 1 | 2002 | 717 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2002 | 694 | 0.010 |
Why?
|
| Dimerization | 1 | 2000 | 304 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2008 | 4804 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2005 | 1152 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 2508 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2005 | 1555 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 3101 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2002 | 750 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 7548 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 14889 | 0.010 |
Why?
|
| Kinetics | 1 | 2000 | 2049 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2012 | 16273 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2005 | 2819 | 0.010 |
Why?
|
| Lymphoma, B-Cell | 1 | 2000 | 895 | 0.010 |
Why?
|
| Child | 1 | 2012 | 29154 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2005 | 5437 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2005 | 7789 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2002 | 7702 | 0.000 |
Why?
|